Cardiometabolic Risk Summit 2018

Cardiometabolic Risk Summit 2018

National Meeting

Instructions

To be eligible for documentation of credit, participants must have attended the Cardiometabolic Risk Summit and complete the online evaluation form. After successful completion of the evaluation form, participants may immediately print their documentation of credit. Please follow the below steps:

  1. Click General Evaluation or Login at the top right of your screen
  2. Login using the email you used to register for the meeting and your temporary password which is: CRS2018. If you registered onsite at the meeting (September 13 or after), your temporary password is not set up and you should choose to create an account. If you already have an existing NACCME account on this site, please use that login email and password.
  3. Successfully complete the General Evaluation and ISS Session Evaluations to be eligible for documentation of credit. These evaluations are accessible by using the menu bar located on the right hand side of the page. You can immediately print your documentation of credit. Your certificate will also be accessible for printing at a later date by logging into your account and visiting the “My Account” tab.

Please complete your online evaluation by October 16, 2018.

For any questions regarding receipt of credit, please email info@naccme.com 

Pharmacology Credits

CRS is approved for 6.13 Pharmacology credits. Please see a listing of sessions and credits below for your reference:

Addressing Your Patient’s Cardiometabolic Risk: Clinical Case, Discussion and Audience Q&A – Part One
0.5 Pharmacology Credits

Reducing Clinical Inertia in Type 2 Diabetes: A Case for Early Combination Therapy
0.5 Pharmacology Credits

Incorporating Long-Acting Insulin Therapy into the Physiologic Approach to Diabetes Management
0.75 Pharmacology Credits

Intensifying Treatment: Is a Combination Therapy Ideal for your Patient with T2DM?
0.25 Pharmacology Credits

The Role of Newer GLP-1 Receptor Agonists in the Treatment of T2DM
0.5 Pharmacology Credits

Updates on CV Outcomes Trial Data: Optimizing Treatment of T2DM
0.5 Pharmacology Credits

The Present & Future of Medical Devices for Diabetes
0.25 Pharmacology Credits

PCSK9 Inhibitors: Update on CV Events and Access Challenges
0.5 Pharmacology Credits

Integrating Non-Statin Therapies into Optimal Treatment Plans
0.25 Pharmacology Credits

The Role of Inflammation in CV Disease: Focus on the CANTOS Trial
0.25 Pharmacology Credits

Lipid-lowering Therapies: What’s New in 2018?
0.25 Pharmacology Credits

Overview & Exceptions to the New Hypertension Guidelines
0.125 Pharmacology Credits

How Do The New Hypertension Guidelines Change Your Practice?
0.125 Pharmacology Credits

Strategies to Address Resistant Hypertension
0.25 Pharmacology Credits

Management of Pulmonary Arterial Hypertension in Primary Care: Advancing Patient Outcomes through Improved Diagnosis and Individualized Treatment
0.25 Pharmacology Credits

Update in the Management of Heart Failure: A Practical, Guideline-Directed Approach
0.25 Pharmacology Credits

Addressing Your Patient’s Cardiometabolic Risk: Management of Complex Hypertension Cases – Part Three
0.125 Pharmacology Credits

Current and Future of Obesity Drug Therapies: Echoes of Today’s Metabolic Treatments
0.5 Pharmacology Credits